There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

Carl Zeiss Meditec has strong fundamentals and growth potential. It has impressive free cash flow and rising shareholder ...

German intelligence began investigating after Zeiss employees flagged these efforts ... One case involved three employees ...

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ZEISS and the HÜBNER Group have unveiled an innovative holographic display technology for public transit, integrating ...

ZEISS Research Microscopy Solutions and AI pathology leader Mindpeak have joined forces to develop an integrated Multiplex ...

The broader Asia-Pacific region was also a weak spot, with organic growth in ophthalmology devices down 4.5% for the year, ...

ZEISS India, a technology expert in optics and optoelectronics, has inaugurated its first ZEISS VISION CENTRE in the city in association with Image Optical Company, a top official said on Tuesday. The ...

ZEISS India and Image Optical Company have launched the first ZEISS VISION CENTRE in Chennai, offering premium eye care solutions and customisation options for customers.

UBS analyst Graham Doyle maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research Report) today and set a price target of €65.00. The ...